Hangzhou, China – October 2025 — Singclean Medical, a leading developer and manufacturer of absorbable biomaterials, will participate in MEDICA 2025 from November 17th to 20th at the Messe Düsseldorf, Germany, located at Hall 16 / H67-3.

Since its establishment in 2002, Singclean Medical has been dedicated to advancing the field of absorbable biomaterials, offering diversified medical innovation solutions including medical aesthetics, natural skincare, hyaluronic acid gels, absorbable hemostatic materials, and in vitro diagnostic reagents. Today, Singclean’s products are registered in over 50 countries and trusted by healthcare professionals and distributors across 80+ countries and regions.
With a strong commitment to quality, innovation, and global collaboration, Singclean invests over 10% of its annual revenue into research and development. The company has evolved into a comprehensive high-tech enterprise integrating R&D, manufacturing, and international marketing, with partnerships established with more than 330 global companies.
At MEDICA 2025, Singclean will present its latest generation of biomaterial solutions, designed to meet the growing global demand for safe, effective, and innovative medical products. More importantly, this exhibition provides an opportunity for Singclean to connect face-to-face with partners and clients, explore new business collaborations, and discuss customized solutions tailored to local markets.
Guided by its philosophy — “Beyond Products, We Build Partnerships” — Singclean Medical looks forward to creating long-term, mutually beneficial relationships with global partners, strengthening its role as a trusted contributor to the global healthcare industry.
Event Details:
Venue: Messe Düsseldorf, Germany
Date: November 17–20, 2025
Booth: Hall 16 / H67-3
For partnership inquiries or meeting arrangements, please contact support@singclean.net.
-
singclean | 2025-10-28
2026 Global Dermal Filler Trend Outlook:As the global medical aesthetics market continues to evolve, consumer and clinician demands for dermal fillers are undergoing an unprecedented paradigm shift. From the early days of "blind filling and chasing volume" to today's focus on "anatomical refinement, natural facial dynamics, and ultimate comfort," the industry has officially entered the Hyaluronic Acid 4.0 Era. In this transformation driven by safety, comfort, longevity, and natural results, innovative Chinese brands like Singderm® are accelerating their breakthrough into the premium global aesthetics landscape, powered by proprietary technologies and rigorous international standards. -
singclean | 2025-10-28
Dual-Exhibition Global Layout! Singclean Medical to Showcase Premium Biomaterials and IVD Innovations at WHX Miami & WHX Bangkok 2026With the rapid advancement and technical iteration of the global healthcare industry, international presence has become the core engine for the sustainable growth of leading medical device enterprises. Hangzhou Singclean Medical Products Co., Ltd. (Singclean Medical), a globally recognized leader in medical biomaterials and In Vitro Diagnostics (IVD), has announced its upcoming participation in two world-class healthcare exhibitions from June to July 2026: WHX Miami (World Health Expo Miami 2026) in the United States and WHX Bangkok (World Health Expo Bangkok 2026) in Thailand. Singclean Medical will seize these opportunities to demonstrate its latest achievements under the dual-wheel drive of "Medical Biomaterials" and "In Vitro Diagnostics," cordially inviting global partners to explore new horizons in medical healthcare. -
singclean | 2025-10-28
Singclean Medical Shines at Mevos 2026 with Two New Singfiller Products, Ushering in a New Decade of Precision Filling